|
Volumn 12, Issue 1, 1996, Pages 141-168
|
Therapy for acute myocardial infarction
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ALTEPLASE;
ANISTREPLASE;
ANTIARRHYTHMIC AGENT;
ANTICOAGULANT AGENT;
ATENOLOL;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BUMETANIDE;
CALCIUM ANTAGONIST;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
DOBUTAMINE;
DOPAMINE;
FIBRINOLYTIC AGENT;
FUROSEMIDE;
GLYCEROL NITRATE;
HEPARIN;
INFUSION FLUID;
MAGNESIUM;
METOPROLOL;
MORPHINE SULFATE;
NORADRENALIN;
STREPTOKINASE;
TIMOLOL;
WARFARIN;
ACUTE HEART INFARCTION;
AGING;
BLEEDING;
CARDIOGENIC SHOCK;
CONGESTIVE HEART FAILURE;
CORONARY ARTERY DILATATION;
DOPPLER ECHOGRAPHY;
ELECTROCARDIOGRAPHY;
FIBRINOLYTIC THERAPY;
HEART ATRIUM FIBRILLATION;
HEART MUSCLE OXYGEN CONSUMPTION;
HEART RUPTURE;
HIGH RISK POPULATION;
HUMAN;
HYPOTENSION;
INTRAVENOUS DRUG ADMINISTRATION;
MEDICAL ETHICS;
MORTALITY;
ORAL DRUG ADMINISTRATION;
REVIEW;
RISK BENEFIT ANALYSIS;
STROKE;
SUBCUTANEOUS DRUG ADMINISTRATION;
SUBLINGUAL DRUG ADMINISTRATION;
TRANSDERMAL DRUG ADMINISTRATION;
|
EID: 0030058810
PISSN: 07490690
EISSN: None
Source Type: Journal
DOI: 10.1016/s0749-0690(18)30250-7 Document Type: Review |
Times cited : (23)
|
References (0)
|